HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Avidity of onconeural antibodies is of clinical relevance.

Abstract
Onconeural antibodies are important in the detection of paraneoplastic neurological syndromes (PNS). The avidity of Hu, Yo, and CRMP5 antibodies from 100 patients was determined by immunoprecipitation (IP), and 13 of the Yo positive sera were also tested by surface plasmon resonance (SPR). There was a significant association between the results from IP and SPR. Yo antibodies had higher avidity than Hu and CRMP5 antibodies, and both high- and low-avidity antibodies were associated with tumors and PNS. High-avidity Yo antibodies were mainly associated with ovarian cancer, whereas high-avidity Hu and CRMP5 antibodies were mainly associated with small-cell lung cancer. Low-avidity CRMP5 and Yo antibodies were less often detected by a commercial line blot than high-avidity antibodies. The failure to detect low-avidity onconeural antibodies may result in under diagnosis of PNS.
AuthorsCecilie Totland, Ming Ying, Mette Haugen, Kibret Mazengia, Anette Storstein, Jan Aarseth, Aurora Martinez, Christian Vedeler
JournalCancer immunology, immunotherapy : CII (Cancer Immunol Immunother) Vol. 62 Issue 8 Pg. 1393-6 (Aug 2013) ISSN: 1432-0851 [Electronic] Germany
PMID23733227 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Neoplasm
  • CDR2 protein, human
  • ELAV Proteins
  • Microtubule-Associated Proteins
  • Nerve Tissue Proteins
  • DPYSL5 protein, human
  • Hydrolases
Topics
  • Antibodies, Neoplasm (blood, immunology)
  • Antibody Affinity
  • ELAV Proteins (immunology)
  • Humans
  • Hydrolases
  • Immunoprecipitation
  • Microtubule-Associated Proteins
  • Nerve Tissue Proteins (immunology)
  • Paraneoplastic Syndromes (blood, diagnosis, immunology)
  • Sensitivity and Specificity
  • Surface Plasmon Resonance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: